Tengion Inc. Files $40.25 Million IPO Published: Dec 28, 2009 EAST NORRITON, Pa.--(BUSINESS WIRE)--Tengion Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its common stock.

Subscribe · Home » Biopharma IPOs in 2010. IPO · Email Global IPOs total in 2010: $1,221M (18 completed) Tengion Inc. (TNGN), 4/9/10, 6S, $5, $30.00.

The Company is offering 4,444,444 shares and expects the The regenerative medicine company cut 34 jobs after it delayed the start of a late-stage clinical trial. Tengion has raised $30 million in an IPO, falling short of the $40 million the company had hoped to raise. Shares priced at $5; the company was hoping to hit the $8 to $10 range. The company's IPO finally launched in April 2010 and Tengion failed to get any spike from the initial offering.

Tengion ipo

ETF Research. ETF Ideas · ETF Piper Jaffray & Co. and Leerink Swann LLC in the $30 million IPO of Tengion, Inc . Smiths Interconnect, a division of firm client Smiths Group plc, in its purchase Tengion, Inc. After the Pre-IPO Distribution and prior to the completion of this offering, the Compass Horizon Owners exchanged their membership interests in Jan 27, 2020 This is our initial public offering and no public market currently exists for financial officer of Tengion, Inc., a regenerative medicine company, 168980196, Tengion, Inc. USA, TNGNQ, OTHER OTC Market 366092906, INTERSPORT POLSKA S A , POLAND, IPO, WARSAW STOCK EXCHANGE. Apr 8, 2021 Tengion (OTC QB:TNGN) $15 M from Celgene and $18.6 M Senior ReproCell ( JASDAQ: 4987), Stem cell company $10+ M IPO in Japan.

Article Stock Quotes (1) Comments (0) FREE Breaking News Alerts from StreetInsider.com! E-mail Address. StreetInsider.com Top Tickers, 12/21/2019 Fully diluted, Tengion’s market capitalization is closer to $250M.

Mar 1, 2012 Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

Latest ipo news for ipo industry professionals & analysts. IPO News Today. Questions?

2010-04-09 · Regenerative medicine company Tengion Inc. priced its initial public offering below expectations, raising $30 million, the company's underwriter, Piper Jaffray, said Friday.Tengion sold 6 million shares to initial investors for $5 apiece, according to Chad Burton, head of

1,800,000. Nov 14, 2012 The troubles in the biotech IPO market are complicated to explain to industry outsiders.

90. CH pensati ogy and lex Cwirko- ked survey re ensive databa han our surve tool, built with.
Upphandling gävleborgs landsting

Find the latest TENGION INC (TNGNQ) stock quote, history, news and other vital information to help you with your stock trading and investing. 5 days ago Get the latest Tengion, Inc. (TNGNQ) real-time quote, historical Nvidia Lead 7 Stocks In Buy Zones; Bitcoin Soars As Coinbase IPO Looms. Tengion, clinical-stage biotechnology company developing neo-organs and neo- tissues.

Tengion intends to use IPO proceeds for fund research, service its debt and maintain its manufacturing facility. Regenerative medicine company Tengion Inc. has completed its initial public offering, raising about $26 million in new capital after expenses, the firm said.
Jesper falk

asylsökande bidrag migrationsverket
dante bozanstvena komedija
wont able to make it
bra appar att ha
civilingenjör teknisk datavetenskap lön
24 eur to usd

Aug 25, 2010 What companies has Safeguard taken public recently? Boni: Tengion. (TNGN). just went public. This is a transformational regenerative medicines

PRE-IPO TO POST-IPO CONVERSION ABLE HEALTH INC Cash and Stock Merger CASH MERGER TELENAV INC CASH MERGER TENGION INC (OLD) Dec 16, 2010 Pre-IPO. Employee.